View our Blog

Market Insights

Close

Subscribe to our newsletter

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.

RESEARCH AND NEWS

Empowering investors with access to the best research, experts and opportunities.

SUBSCRIBE

THIS WEEK'S NEWS

Why the FDA backs ASX-biotech to revolutionise cancer treatment
One in five people will get cancer in their lifetime – almost everyone has been touched by the disease in one way or another.
| 4 July 2025
Pitt Street Research briefing on Prescient Therapeutics (ASX: PTX)
| 11 July 2025
Prescient Therapeutics – Live Investor Briefing – Pitt Street Research
| 9 July 2025
Why the FDA backs ASX-biotech to revolutionise cancer treatment
| 4 July 2025

More posts

Pitt Street Research briefing on Prescient Therapeutics (ASX: PTX)
Prescient Therapeutics – Live Investor Briefing – Pitt Street Research
Why the FDA backs ASX-biotech to revolutionise cancer treatment
Prescient Therapeutics
Prescient Therapeutics (ASX: PTX) Webcast Replay
Felix Gold (ASX: FXG) Webcast Replay
Protected: Wholesale Investment Opportunity

WEBCASTS AND MEDIA

Prescient Therapeutics (ASX: PTX) Webcast Replay
| 2 July 2025
View All Webcasts
Join our next webcast

NEWS

See all news

RESEARCH

Why the FDA backs ASX-biotech to revolutionise cancer treatment
|
The Aussie mining veterans looking to build the largest exploration company on the planet
| 14 May 2025
Felix Gold: The Leading U.S. Antimony Solution at a Critical Moment
| 3 April 2025
Aussie big data company disrupts the ~$300bn pork industry
| 26 March 2025
The sector that is growing despite (or because of) Trump
| 18 March 2025
Australia’s Best Performing Fund – Here’s Why
| 28 February 2025
See all research
Close
Search

Hit enter to search or ESC to close